Metuchen Pharmaceuticals is a privately-held healthcare company with offices in Cranford, NJ. The company recently acquired the rights to Stendra® (avanafil tablets), a novel PDE-5 inhibitor for the treatment of erectile dysfunction (ED). Metuchen is currently offering partners the opportunity to license Stendra in Canada, India and South America.

Click here for full Stendra Prescribing Information.